Great Lakes Advisors LLC Has $10.04 Million Holdings in GE HealthCare Technologies Inc. $GEHC

Great Lakes Advisors LLC grew its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 48.7% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 156,796 shares of the company’s stock after acquiring an additional 51,374 shares during the quarter. Great Lakes Advisors LLC’s holdings in GE HealthCare Technologies were worth $10,036,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Vanguard Group Inc. raised its stake in GE HealthCare Technologies by 0.5% during the 4th quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock valued at $4,287,658,000 after purchasing an additional 267,058 shares during the last quarter. Auto Owners Insurance Co increased its holdings in shares of GE HealthCare Technologies by 9,525.4% during the 4th quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock worth $278,725,000 after purchasing an additional 33,629,559 shares during the period. Dodge & Cox increased its holdings in shares of GE HealthCare Technologies by 13.4% during the 4th quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock worth $2,559,945,000 after purchasing an additional 3,693,918 shares during the period. Capital Research Global Investors raised its position in shares of GE HealthCare Technologies by 1.6% during the fourth quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock valued at $2,080,248,000 after buying an additional 389,796 shares during the last quarter. Finally, State Street Corp raised its position in shares of GE HealthCare Technologies by 2.0% during the fourth quarter. State Street Corp now owns 20,049,677 shares of the company’s stock valued at $1,644,475,000 after buying an additional 401,932 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Insider Transactions at GE HealthCare Technologies

In other GE HealthCare Technologies news, Director Kevin Lobo bought 10,000 shares of the stock in a transaction on Friday, May 22nd. The stock was purchased at an average price of $64.18 per share, with a total value of $641,800.00. Following the acquisition, the director owned 14,363 shares of the company’s stock, valued at approximately $921,817.34. The trade was a 229.20% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Stock Up 0.4%

GEHC opened at $72.63 on Wednesday. The firm’s 50-day simple moving average is $66.01 and its 200-day simple moving average is $69.63. The company has a debt-to-equity ratio of 0.92, a quick ratio of 0.97 and a current ratio of 1.26. GE HealthCare Technologies Inc. has a twelve month low of $58.75 and a twelve month high of $89.77. The firm has a market cap of $32.81 billion, a price-to-earnings ratio of 16.66, a PEG ratio of 2.13 and a beta of 0.69.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, July 29th. The company reported $1.13 earnings per share for the quarter, beating analysts’ consensus estimates of $1.04 by $0.09. The firm had revenue of $5.29 billion during the quarter, compared to analysts’ expectations of $5.26 billion. GE HealthCare Technologies had a return on equity of 20.12% and a net margin of 9.33%.The business’s revenue was up 5.8% on a year-over-year basis. During the same period last year, the firm posted $1.06 EPS. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.93 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Friday, July 24th were paid a $0.035 dividend. The ex-dividend date of this dividend was Friday, July 24th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.21%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the company. UBS Group lifted their target price on GE HealthCare Technologies from $67.00 to $73.00 and gave the stock a “neutral” rating in a research report on Friday, July 31st. Piper Sandler reiterated a “buy” rating on shares of GE HealthCare Technologies in a research report on Wednesday, July 29th. Barclays decreased their price objective on GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a report on Thursday, April 30th. Citigroup boosted their price objective on GE HealthCare Technologies from $69.00 to $75.00 and gave the company a “neutral” rating in a research report on Thursday, July 30th. Finally, BNP Paribas Exane cut their target price on GE HealthCare Technologies from $95.00 to $88.00 in a research note on Friday, May 1st. Ten equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Hold” and an average target price of $77.73.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.